Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
2.12M
-
Shares change
-
+1.23M
-
Total reported value, excl. options
-
$16.1M
-
Value change
-
+$10.1M
-
Put/Call ratio
-
0.33
-
Number of buys
-
37
-
Number of sells
-
-4
-
Price
-
$7.62
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q1 2020
50 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q1 2020.
Co-Diagnostics, Inc. - Common Stock (CODX) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.12M shares
of 38.5M outstanding shares and own 5.5% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (777K shares), MORGAN STANLEY (368K shares), GEODE CAPITAL MANAGEMENT, LLC (121K shares), MILLENNIUM MANAGEMENT LLC (104K shares), CITADEL ADVISORS LLC (101K shares), JANE STREET GROUP, LLC (67.9K shares), Harvest Investment Services, LLC (64.7K shares), IFG Advisory, LLC (61.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (51.3K shares), and Wealth Architects, LLC (40K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.